Innate immune recognition of lipopolysaccharide by endothelial cells

被引:64
作者
Henneke, P [1 ]
Golenbock, DT [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA USA
关键词
bacterial DNA; lipopolysaccharide; sepsis; signal transduction; Toll-like receptors;
D O I
10.1097/00003246-200205001-00006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. The endothelium is an active component of the innate immune response to bacterial invasion. Endothelial cells comprise mechanisms to recognize structural patterns expressed by pathogens and subsequently initiate the transcription of inflammatory genes. The purpose of this article is to summarize the molecular processes that underlie the endothelial innate immune response to microbial components, with a particular focus on responses to Gram-negative bacterial lipopolysaccharide. Data Sources: Personal observations and review of the literature as revealed by the National Library of Medicine. Data Summary and Conclusion: Endothelial cells recognize the presence of microbial components such as lipopolysaccharide via a receptor complex that contains at least three important cell surface components: CD14, Toll-like receptor-4, and MD-2. CD14 and MD-2 exist as soluble receptor components and are thought to bind to both lipopolysaccharide and Toll-like receptor-4, whereas Toll-like receptor-4 itself is the transmembrane signal transducer. Single-point mutations in MD-2 or the cytoplasmic portion of Toll-like receptor-4 abrogate the response to lipopolysaccharide. The composition of this receptor and the recruitment and activation of various cytoplasmic proteins afford at least five levels of ligand specificity and suggest that there are at least as many potential therapeutic targets for Toll-like receptor-mediated inflammatory states, including sepsis.
引用
收藏
页码:S207 / S213
页数:7
相关论文
共 87 条
[1]   Decreased expression of toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide [J].
Abreu, MT ;
Vora, P ;
Faure, E ;
Thomas, LS ;
Arnold, ET ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1609-1616
[2]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[3]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[4]   Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Mark, MR ;
Suggett, S ;
Devaux, B ;
Radolf, JD ;
Klimpel, GR ;
Godowski, P ;
Zychlinsky, A .
SCIENCE, 1999, 285 (5428) :736-739
[5]   Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B [J].
Anrather, J ;
Csizmadia, V ;
Brostjan, C ;
Soares, MP ;
Bach, FH ;
Winkler, H .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) :763-772
[6]   Toll-like receptor 2-mediated NF-κB activation requires a RacI-dependent pathway [J].
Arbibe, L ;
Mira, JP ;
Teusch, N ;
Kline, L ;
Guha, M ;
Mackman, N ;
Godowski, PJ ;
Ulevitch, RJ ;
Knaus, UG .
NATURE IMMUNOLOGY, 2000, 1 (06) :533-540
[7]   Protective genes expressed in endothelial cells: a regulatory response to injury [J].
Bach, FH ;
Hancock, WW ;
Ferran, C .
IMMUNOLOGY TODAY, 1997, 18 (10) :483-486
[8]   Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial tells through inhibition of NF-κB [J].
Badrichani, AZ ;
Stroka, DM ;
Bilbao, G ;
Curiel, DT ;
Bach, FH ;
Ferran, C .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (04) :543-553
[9]  
BEEKHUIZEN H, 1991, J IMMUNOL, V147, P3761
[10]   Cooperation of toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein:: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling [J].
Bulut, Y ;
Faure, E ;
Thomas, L ;
Equils, O ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :987-994